Elan Corporation(DRX)

Sector:

Medicine and Biotech Research

Index:

ISEQ 20 Return Index

Market Cap

€ 4,591.45m

Closing Price Change

Price Up€ 0.59

Share Price

€ 9.77

DRX Overview

Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain. It has offices in Dublin and Athlone in Ireland, Georgia, Pennsylvania, New York and California in the US and in the UK and Japan.

3 Month Chart (29-Aug-2008)

3 Month Chart

1 Year Chart

1 Year Chart

Income & Efficiency

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -34.9% -25.7%
ROCE -37.1%  

Valuation

Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 15.9 6.9
Pr/Book n/a  

Growth

Latest F'cast
Revenue 35.5% 29.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

DRX Market Data

Currency Euro
52 Week High € 23.47
52 Week Low € 7.08
Shares Issued 470.20m
Market Cap € 4,591.45m
Beta 0.80

What The Brokers Say

Strong Buy 6
Buy 1
Neutral 8
Sell 0
Strong Sell 2
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DRX Dividends

No dividends found

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).